Roche
Search results
Genentech's legacy and future aspirations are built on the belief that the boundaries of science are meant to be broken and that we can solve some of the hardest biomedical challenges plaguing humankind.
- Advancing Inclusive Research
Advancing Inclusive Research ® (AIR) is an innovative...
- Patient Financial Support
If you need help understanding your health insurance...
- Clinical Trial Information
In rare circumstances, Genentech may provide patients with...
- Our Pipeline
Pipeline. Rigorous and groundbreaking science has always...
- Our Medicines
You may also report side effects to Genentech at (888)...
- Featured Topics
Genentech Patient Foundation; Clinical Trials; Patient...
- Hematology
Find Genentech stories by topic. Hematology. Learn about the...
- Giving
We also support the Genentech Foundation, a U.S.-based,...
- Advancing Inclusive Research
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.
Genentech is a biotechnology company that discovers and develops medicines for serious and life-threatening diseases. Learn about its history, mission, values, and podcast series on human biology.
Find prescribing information, medication guides, healthcare provider letters, and safety data sheets for Genentech's biologic products. Browse by product name, indication, or therapeutic area.
Genentech | 749,830 followers on LinkedIn. About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions.
Genentech is a biotechnology company that develops and markets medicines for various diseases. Learn about their medicines, coverage options, clinical trials, and patient support programs.
Genentech is committed to defeating cancer. Building upon our legacy as pioneers in oncology, we're boldly innovating beyond the science and envision a better future for every cancer patient, caregiver, and provider. We can't do it alone.
